Evidence map›Paper›PMID 39068586›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2024

Anti-Angiogenic and Anti-Proliferative Activity of 4-2-(5-bromo-1H-indol-2-carbonyl)-N-(4-methoxyphenyl) Hydrazine-1-carbothioamide: Ex-vivo and in vitro Study.

Ahmed K Aldhalmi, Hayder B Sahib, Omeed M Hassan, Ammar A Razzak Mahmood, Lubna H Tahtamouni

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed K AldhalmiDepartment of Biochemistry, College of Pharmacy, Al-Mustaqbal University, Iraq.
Hayder B SahibDepartment of Pharmacology and Toxicology, College of Pharmacy, Al-Nahrain University, Iraq.
Omeed M HassanDepartment of Pharmaceutical Chemistry, College of Pharmacy, Karkuk University, Iraq.
Ammar A Razzak MahmoodDepartment of Pharmaceutical Chemistry, College of pharmacy, University of Baghdad, Iraq.
Lubna H TahtamouniDepartment of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis, the formation of new blood vessels, stimulates tumor growth and spread by delivering oxygen and nutrients, and is a key component of metastasis. This work aimed to evaluate the anti-angiogenic properties of a new synthesized compound. Rat aorta angiogenesis assay was used to evaluate the ability of the carbothioamide derivative to inhibit blood vessels sprouting. The tetrazolium (MTT) assay was used to evaluate the anti-proliferative effect of the synthetic compound on human umbilical vein endothelial cell line (HUVECs) and A549 lung cancer cells line. The (2, 2-diphenyl-1-picrylhydrazyl) DPPH was used to investigate the free radical scavenging action. The study showed that the compound has anti-angiogenic activity with IC50 56.9 µg/mL, moreover the compound managed to inhibit the proliferation of HUVECs and A549 cells (IC50 76.3 µg/mL and 45.5 µg/mL, respectively), and The IC50 concentration for free radical scavenging activity of the compound was 27.8 µg/ml. The study concluded that the compound has significant anti-angiogenic activity may be related to its significant anti-proliferative effect against HUVECs, these pharmacological effect may attributed to its potent free radical scavenging activity.

Indexed as

Angiogenesis InhibitorsCell ProliferationHuman Umbilical Vein Endothelial CellsA549 CellsAnimalsAntineoplastic AgentsHumansHydrazinesLung NeoplasmsMaleNeovascularization, PathologicRatsThioamidesAngiogenesis InhibitorsAntineoplastic AgentsHydrazinesThioamidescancer cell lineDPPHKeyword : AngiogenesisMTT assayRat aorta ring

Identifiers

PMID39068586
PMCPMC11480602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.